FASCINATION ABOUT LDN-27219 DRUG MECHANISM OF ACTION

In contrast to neurodegerative conditions and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has long been quite nicely set up. The deamidation of certain glutamine residues targeted by TG2 in gluten peptides continues to be demonstrated to reinforce peptide binding on the ailment-linked proteins HLA-DQ2/8, which can be the s